Wed at 10:27 AM -
Swiss group DKSH has agreed to acquire NewBridge Pharmaceuticals in a transaction valued at $390 million, expanding its healthcare business into the Middle East and North Africa through a company with offices in Egypt, Algeria and Morocco.
News Source
Get the latest innovation, technology and business news from Africa alongside features on lifestyle, markets and more verticals.
Comment